LAB
INDEX
Showing search results for "Photodynamic Therapy"
Impact
Papers
Jobs
Conferences
Name
Impact
?
Papers
Institution
Country
Funding
Hamblin, Michael R
247.7
26
Massachusetts General Hospital
USA
$1,923,880.00
Golab, Jakub
215.5
3
Medical University of Warsaw
Poland
-
Sabatini, David M
198
11
Whitehead Institute for Biomedical Research
USA
$8,465,572.00
Pandey, Ravindra K
130.5
4
Roswell Park Cancer Institute
USA
$5,813,280.00
Guan, Kun-Liang
116.1
7
University of California at San Diego
USA
$8,247,035.00
Hall, Michael N
114.6
8
University of Basel
Switzerland
-
Burgess, Kevin
96.8
2
College Station
USA
$2,451,188.00
Blenis, John
88.7
5
Harvard Medical School
USA
$7,927,669.00
Chi, Hongbo
88.3
5
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
USA
$3,355,107.00
Powell, Jonathan D
77.2
7
Johns Hopkins University School of Medicine
USA
$7,207,880.00
Sonenberg, N
71.8
8
N/A
-
Zhang, Yaou
70.9
2
Tsinghua University
China
-
Wulf, H C
69.2
8
University of Copenhagen
Denmark
-
Hasan, Tayyaba
67.4
6
Harvard Medical School
USA
$15,187,250.00
Durand, Jean-Olivier
65.6
5
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
France
-
Olivo, Malini
65.3
4
National Cancer Centre, Division of Medical Sciences
Singapore
-
Curnow, A
64.7
10
Royal Cornwall Hospital
UK
-
Korbelik, M
64.3
8
Wayne State University
USA
-
Ruggero, Davide
62.8
2
University of California
USA
$4,325,137.00
Chen, Jie
60.6
12
University of Illinois at Urbana-Champaign
USA
$4,353,532.00
Li, Xiaoxia
57.6
6
Cleveland Clinic Foundation
USA
$8,474,304.00
Blagosklonny, Mikhail V
57.2
11
Roswell Park Cancer Institute
USA
-
Chen, Xiangmei
53.8
3
PLA General Hospital and Military Medical Postgraduate College
China
-
Anderson, R Rox
53.6
6
Harvard Medical School
USA
-
Hortobagyi, Gabriel N
53.3
1
Harvard Medical School
USA
$5,015,622.00
Inoue, Yoshikazu
53.3
1
University of Cincinnati
USA
-
Shah, Manisha H
53.3
1
University of Texas M.D. Anderson Cancer Center
USA
-
Wüthrich, Rudolf P
53.3
1
University Hospital and the University of Zurich
Switzerland
-
Horton, Maureen R
52.8
1
Johns Hopkins University School of Medicine
USA
-
Hopper, Colin
51.1
5
University College Hospital
UK
-
Weiss, William A
49
4
University of California
USA
$9,918,314.00
Shrikant, Protul A
48.6
3
Roswell Park Cancer Institute
USA
-
Maytin, Edward V
47.4
5
Cleveland Clinic
USA
$3,137,436.00
Awazu, Kunio
47.4
4
Graduate School of Engineering
Japan
-
Yang, Yunsheng
46.8
2
Chinese PLA General Hospital
China
-
Huang, Shile
46.7
11
Louisiana State University Health Sciences Center
USA
$403,994.00
Zhang, Hongbing
46.4
6
Chinese Academy of Medical Sciences & Peking Union Medical College
China
-
Snyder, Solomon H
46.1
2
Johns Hopkins University School of Medicine
USA
$34,627,626.00
Chen, Qian
44.9
6
Rhode Island Hospital and Brown University
USA
$18,566,762.00
Ikeda, Norihiko
44.8
3
Tokyo Medical University
Japan
-
Baur, Joseph A
44.3
2
Massachusetts Institute of Technology
USA
$1,594,283.00
Hwang, Kuo Chu
44.2
2
National Tsing Hua University
Taiwan
-
Lai, Ping-Shan
43.2
4
National Taiwan University
Taiwan
-
Narita, Masako
42.9
2
Cambridge Research Institute
UK
-
Huang, Zheng
42.7
7
Shanghai Skin Diseases and STD Hospital
China
-
Agostinis, Patrizia
42.7
5
Catholic University of Leuven
Belgium
-
Robinson, Dominic J
42.3
7
Center for Optical Diagnostics and Therapy, Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.
Netherlands
-
Gu, Ying
41.9
5
Chinese Academy of Sciences
China
$687,397.00
Hengstschläger, M
41.5
10
Medical University of Vienna
Austria
-
Gomer, Charles J
41.4
4
Children's Hospital Los Angeles
USA
-
Name
Institution
Date
Impact
Publication
Golab, Jakub
Medical University of Warsaw
05/26/2011
101.70
CA: a cancer journal for clinicians
Photodynamic therapy of cancer: an update.
Abstract
Hortobagyi, Gabriel N
Harvard Medical School
12/07/2011
53.29
The New England journal of medicine
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
Abstract
Inoue, Yoshikazu
University of Cincinnati
03/16/2011
53.29
The New England journal of medicine
Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
Abstract
Shah, Manisha H
University of Texas M.D. Anderson Cancer Center
02/10/2011
53.29
The New England journal of medicine
Everolimus for advanced pancreatic neuroendocrine tumors.
Abstract
Wüthrich, Rudolf P
University Hospital and the University of Zurich
06/26/2010
53.29
The New England journal of medicine
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Abstract
Horton, Maureen R
Johns Hopkins University School of Medicine
11/29/2011
52.76
Annual review of immunology
Regulation of immune responses by mTOR.
Abstract
Guan, Kun-Liang
University of California at San Diego
01/30/2013
39.12
Nature reviews. Molecular cell biology
Amino acid signalling upstream of mTOR.
Abstract
Blenis, John
Harvard Medical School
04/02/2009
39.12
Nature reviews. Molecular cell biology
Molecular mechanisms of mTOR-mediated translational control.
Abstract
Ruggero, Davide
University of California
02/22/2012
36.28
Nature
The translational landscape of mTOR signalling steers cancer initiation and metastasis.
Abstract
Yang, Yaping
Texas Children's Hospital
09/29/2013
35.53
Nature genetics
Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism.
Abstract
Chi, Hongbo
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
04/20/2012
33.28
Nature reviews. Immunology
Regulation and function of mTOR signalling in T cell fate decisions.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
04/16/2012
32.40
Cell
mTOR signaling in growth control and disease.
Abstract
Snyder, Solomon H
Johns Hopkins University School of Medicine
12/14/2010
32.40
Cell
Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
05/14/2009
32.40
Cell
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.
Abstract
Hall, Michael N
University of Basel
02/21/2013
31.20
Science (New York, N.Y.)
Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Abstract
Baur, Joseph A
Massachusetts Institute of Technology
03/30/2012
31.20
Science (New York, N.Y.)
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
06/10/2011
31.20
Science (New York, N.Y.)
The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.
Abstract
Blenis, John
Harvard Medical School
06/10/2011
31.20
Science (New York, N.Y.)
Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.
Abstract
Narita, Masashi
Cancer Research UK Cambridge Research Institute (CRI)
04/21/2011
31.20
Science (New York, N.Y.)
Spatial coupling of mTOR and autophagy augments secretory phenotypes.
Abstract
Hall, Michael N
University of Basel
10/31/2011
29.00
Nature reviews. Drug discovery
Rapamycin passes the torch: a new generation of mTOR inhibitors.
Abstract
Burgess, Kevin
College Station
09/26/2012
28.76
Chemical Society reviews
BODIPY dyes in photodynamic therapy.
Abstract
Pandey, Ravindra K
Roswell Park Cancer Institute
08/09/2010
28.76
Chemical Society reviews
The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
Abstract
Weiss, William A
University of California
10/18/2013
26.56
Cancer cell
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Abstract
Ruggero, Davide
University of California
03/15/2010
26.56
Cancer cell
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
02/02/2009
26.56
Cancer cell
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
02/27/2011
26.00
Nature immunology
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.
Abstract
Chi, Hongbo
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
09/19/2010
26.00
Nature immunology
The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells.
Abstract
Zhang, Yong
National University of Singapore
09/16/2012
22.46
Nature medicine
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers.
Abstract
Li, Xiaoxia
Cleveland Clinic Foundation
11/08/2012
21.63
Immunity
Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance.
Abstract
Guan, Kun-Liang
University of California at San Diego
10/17/2011
21.63
Annual review of pharmacology and toxicology
AMPK and mTOR in cellular energy homeostasis and drug targets.
Abstract
Shrikant, Protul A
Roswell Park Cancer Institute
04/22/2011
21.63
Immunity
A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.
Abstract
Li, Xiaoxia
Cleveland Clinic Foundation
01/07/2010
21.63
Immunity
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
Abstract
Shrikant, Protul A
Roswell Park Cancer Institute
01/07/2010
21.63
Immunity
The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
06/22/2009
21.63
Immunity
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.
Abstract
Guan, Kun-Liang
University of California at San Diego
01/17/2013
19.48
Nature cell biology
YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.
Abstract
Chen, Xiaoyuan
Nanjing University
02/13/2013
15.41
Advanced materials (Deerfield Beach, Fla.)
Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars.
Abstract
Sonenberg, Nahum
McGill University
08/26/2013
14.73
Neuron
Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
10/22/2010
14.17
Molecular cell
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.
Abstract
Sonenberg, Nahum
McGill University
03/29/2010
14.17
Molecular cell
Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission.
Abstract
Hwang, Kuo Chu
National Tsing Hua University
10/18/2013
13.73
Angewandte Chemie (International ed. in English)
Photosensitization of singlet oxygen and in vivo photodynamic therapeutic effects mediated by PEGylated W(18)O(49) nanowires.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
08/22/2013
13.66
Cell metabolism
A Central role for mTOR in lipid homeostasis.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
08/13/2012
13.66
Cell metabolism
DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity.
Abstract
Snyder, Solomon H
Johns Hopkins University School of Medicine
02/02/2011
13.66
Cell metabolism
Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.
Abstract
Guan, Kun-Liang
University of California at San Diego
04/09/2009
13.66
Cell metabolism
Critical role for hypothalamic mTOR activity in energy balance.
Abstract
Sonenberg, Nahum
McGill University
04/19/2011
13.50
Cell host & microbe
Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection.
Abstract
Chi, Hongbo
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
11/25/2013
13.06
The Journal of clinical investigation
Tuning mTOR activity for immune balance.
Abstract
Baur, Joseph A
Massachusetts Institute of Technology
03/01/2013
13.06
The Journal of clinical investigation
Rapalogs and mTOR inhibitors as anti-aging therapeutics.
Abstract
Zhang, Hongbing
Chinese Academy of Medical Sciences & Peking Union Medical College
12/28/2009
13.06
The Journal of clinical investigation
Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.
Abstract
Hall, Michael N
University of Basel
09/29/2011
12.89
Current opinion in cell biology
mTOR signaling in disease.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
11/27/2009
12.89
Current opinion in cell biology
mTOR and cancer: many loops in one pathway.
Abstract
Hall, Michael N
University of Basel
03/02/2009
12.89
Current opinion in cell biology
mTOR and the control of whole body metabolism.
Abstract
Hall, Michael N
University of Basel
03/21/2012
12.35
Trends in cell biology
Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling.
Abstract
Narita, Masako
Cambridge Research Institute
03/11/2009
11.65
Genes & development
Autophagy mediates the mitotic senescence transition.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
08/14/2012
11.14
Immunological reviews
mTOR, metabolism, and the regulation of T-cell differentiation and function.
Abstract
Guan, Kun-Liang
University of California at San Diego
03/01/2013
10.84
Trends in biochemical sciences
Nutrient signaling to mTOR and cell growth.
Abstract
Blenis, John
Harvard Medical School
04/30/2011
10.84
Trends in biochemical sciences
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.
Abstract
Gu, Yueqing
China Pharmaceutical University
12/24/2012
10.77
ACS nano
In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
06/28/2012
10.35
Trends in molecular medicine
Amino acids and mTORC1: from lysosomes to disease.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
06/21/2010
10.26
The Journal of cell biology
Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis.
Abstract
Sonenberg, Nahum
McGill University
05/18/2012
9.81
Proceedings of the National Academy of Sciences of the United States of America
Distinct perturbation of the translatome by the antidiabetic drug metformin.
Abstract
Hall, Michael N
University of Basel
06/03/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
mTOR complex 2 in adipose tissue negatively controls whole-body growth.
Abstract
Chi, Hongbo
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
05/28/2013
9.52
Current opinion in immunology
mTOR and lymphocyte metabolism.
Abstract
Hwang, Kuo Chu
National Tsing Hua University
12/16/2013
8.35
Small (Weinheim an der Bergstrasse, Germany)
First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation.
Abstract
Lai, Ping-Shan
National Chung Hsing University
04/17/2012
8.35
Small (Weinheim an der Bergstrasse, Germany)
Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
09/26/2013
7.86
Cancer research
Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A.
Abstract
Sonenberg, Nahum
McGill University
10/24/2012
7.86
Cancer research
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
Abstract
Maytin, Edward V
Cleveland Clinic
08/01/2011
7.86
Cancer research
Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.
Abstract
Zhang, Hongbing
Chinese Academy of Medical Sciences & Peking Union Medical College
01/04/2011
7.86
Cancer research
Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.
Abstract
Golab, Jakub
Medical University of Warsaw
05/12/2009
7.86
Cancer research
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
01/27/2009
7.86
Cancer research
Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
Abstract
Ikeda, Norihiko
Tokyo Medical University
03/23/2010
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
Abstract
Maytin, Edward V
Cleveland Clinic
05/15/2009
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
Abstract
Hengstschläger, Markus
Medical University of Vienna
06/08/2009
7.64
Human molecular genetics
Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle.
Abstract
Weiss, William A
University of California
11/09/2010
7.50
Science signaling
Akt and autophagy cooperate to promote survival of drug-resistant glioma.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
04/21/2009
7.50
Science signaling
The pharmacology of mTOR inhibition.
Abstract
Weiss, William A
University of California
01/27/2009
7.50
Science signaling
EGFR signals to mTOR through PKC and independently of Akt in glioma.
Abstract
Zhang, Hongbing
Chinese Academy of Medical Sciences & Peking Union Medical College
11/01/2013
7.45
Autophagy
MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1.
Abstract
Agostinis, Patrizia
Catholic University of Leuven
06/19/2013
7.45
Autophagy
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
11/28/2012
7.45
Autophagy
Hypoxia, MTOR and autophagy: converging on senescence or quiescence.
Abstract
Weiss, William A
University of California
05/01/2011
7.45
Autophagy
Autophagy and Akt promote survival in glioma.
Abstract
Zhang, Hongjie
Chinese Academy of Sciences (CAS)
07/13/2013
7.40
Biomaterials
Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy.
Abstract
Lai, Ping-Shan
National Chung Hsing University
10/12/2012
7.40
Biomaterials
Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy.
Abstract
Chen, J
University of Wollongong
08/22/2011
7.04
Obesity reviews : an official journal of the International Association for the Study of Obesity
Multiple signal pathways in obesity-associated cancer.
Abstract
Durand, Jean-Olivier
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
02/18/2009
6.72
Chemical communications (Cambridge, England)
Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Abstract
Guan, Kun-Liang
University of California at San Diego
07/27/2011
6.60
Development (Cambridge, England)
An emerging role for TOR signaling in mammalian tissue and stem cell physiology.
Abstract
Olivo, Malini
National Cancer Centre, Division of Medical Sciences
03/31/2009
6.57
Cellular and molecular life sciences : CMLS
The effect of photodynamic therapy on tumor angiogenesis.
Abstract
Chi, Hongbo
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105
02/01/2013
6.39
Seminars in immunology
mTOR and metabolic pathways in T cell quiescence and functional activation.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
01/14/2013
6.39
Seminars in immunology
Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function.
Abstract
Zhang, H
Peking Union Medical College and Chinese Academy of Medical Sciences
09/30/2013
6.37
Oncogene
Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex.
Abstract
Hengstschläger, M
Medical University of Vienna
05/23/2011
6.37
Oncogene
Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
Abstract
Hengstschläger, M
Medical University of Vienna
11/23/2009
6.37
Oncogene
Embryoid body formation of human amniotic fluid stem cells depends on mTOR.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
04/12/2012
5.95
Neoplasia (New York, N.Y.)
Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.
Abstract
Durand, Jean-Olivier
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
05/25/2010
5.91
Nanoscale
Silica-based nanoparticles for photodynamic therapy applications.
Abstract
Sonenberg, Nahum
McGill University
01/12/2010
5.83
Chemistry & biology
A chemical genetic screen for mTOR pathway inhibitors based on 4E-BP-dependent nuclear accumulation of eIF4E.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
05/04/2012
5.79
Journal of immunology (Baltimore, Md. : 1950)
Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.
Abstract
Lai, Ping-Shan
National Chung Hsing University
06/12/2011
5.73
Journal of controlled release : official journal of the Controlled Release Society
Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
08/08/2013
5.70
Carcinogenesis
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
06/05/2013
5.56
Journal of lipid research
Mechanistic target of rapamycin controls homeostasis of adipogenesis.
Abstract
Chen, Qun
South China Normal University
07/06/2011
5.54
European journal of cancer (Oxford, England : 1990)
New insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapy.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
08/19/2013
5.42
Free radical biology & medicine
Thiocyanate potentiates antimicrobial photodynamic therapy: in situ generation of the sulfur trioxide radical anion by singlet oxygen.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
10/06/2012
5.42
Free radical biology & medicine
Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
09/09/2013
5.36
Cell cycle (Georgetown, Tex.)
S6K in geroconversion.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
08/22/2013
5.36
Cell cycle (Georgetown, Tex.)
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
09/17/2012
5.36
Cell cycle (Georgetown, Tex.)
Hypoxia and gerosuppression: the mTOR saga continues.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
12/15/2010
5.36
Cell cycle (Georgetown, Tex.)
Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal.
Abstract
Shrikant, Protul A
Roswell Park Cancer Institute
08/12/2010
5.36
Cell cycle (Georgetown, Tex.)
Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation?
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
06/21/2009
5.36
Cell cycle (Georgetown, Tex.)
At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.
Abstract
Blenis, John
Harvard Medical School
02/18/2009
5.36
Cell cycle (Georgetown, Tex.)
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy.
Abstract
Burgess, Kevin
College Station
09/24/2013
5.25
Journal of medicinal chemistry
Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent.
Abstract
Pandey, Ravindra K
Roswell Park Cancer Institute
09/06/2011
5.25
Journal of medicinal chemistry
In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
05/20/2010
5.25
Journal of medicinal chemistry
In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers.
Abstract
Pandey, Ravindra K
Roswell Park Cancer Institute
07/16/2009
5.25
Journal of medicinal chemistry
Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
06/13/2012
5.13
Aging
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
01/20/2011
5.13
Aging
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
07/07/2010
5.13
Aging
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Abstract
Li, Xuejun
Peking University
11/22/2011
5.08
Molecular oncology
Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
10/29/2012
5.06
Nanomedicine : nanotechnology, biology, and medicine
Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C₇₀ and C₈₄O₂ Fullerene Derivatives.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
11/29/2011
5.06
Nanomedicine (London, England)
Photodynamic therapy with fullerenes in vivo: reality or a dream?
Abstract
Hamblin, M R
Medical University of Graz
09/24/2013
5.04
British journal of cancer
Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.
Abstract
Korbelik, M
Wayne State University
02/19/2009
5.04
British journal of cancer
Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
09/25/2013
4.94
Molecular biology of the cell
Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis.
Abstract
Pandey, Ravindra K
Roswell Park Cancer Institute
05/20/2010
4.93
Bioconjugate chemistry
Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
07/13/2010
4.91
Cancer prevention research (Philadelphia, Pa.)
Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
04/02/2010
4.89
The American journal of pathology
Rapamycin extends maximal lifespan in cancer-prone mice.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
09/19/2011
4.84
Antimicrobial agents and chemotherapy
Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.
Abstract
Agostinis, Patrizia
Catholic University of Leuven
08/30/2010
4.79
Apoptosis : an international journal on programmed cell death
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.
Abstract
Lai, Ping-Shan
National Taiwan University
08/02/2010
4.78
Molecular pharmaceutics
Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d,l-lactide) diblock copolymer in vivo.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
10/31/2012
4.77
The Journal of biological chemistry
Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
08/18/2011
4.77
The Journal of biological chemistry
Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
07/07/2011
4.77
The Journal of biological chemistry
Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.
Abstract
Guan, Kun-Liang
University of California at San Diego
08/18/2009
4.75
American journal of physiology. Endocrinology and metabolism
Critical roles for the TSC-mTOR pathway in β-cell function.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
02/03/2009
4.75
American journal of physiology. Endocrinology and metabolism
Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytes.
Abstract
Li, Xuejun
Peking University
01/25/2012
4.63
The international journal of biochemistry & cell biology
Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1.
Abstract
Hasan, Tayyaba
Harvard Medical School
10/11/2012
4.41
Journal of the National Comprehensive Cancer Network : JNCCN
Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies.
Abstract
Gomer, Charles J
Children's Hospital Los Angeles
10/11/2012
4.41
Journal of the National Comprehensive Cancer Network : JNCCN
Induction of prosurvival molecules during treatment: rethinking therapy options for photodynamic therapy.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
08/07/2013
4.34
Journal of biophotonics
CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
09/14/2012
4.34
Journal of biophotonics
Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion.
Abstract
Robinson, Dominic J
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
08/15/2011
4.34
Journal of biophotonics
Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis.
Abstract
Hasan, Tayyaba
Harvard Medical School
05/25/2010
4.34
Journal of biophotonics
Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.
Abstract
Maytin, Edward V
Cleveland Clinic
07/25/2012
4.24
Cancer letters
Biomodulatory approaches to photodynamic therapy for solid tumors.
Abstract
Hasan, Tayyaba
Harvard Medical School
01/18/2012
4.24
Cancer letters
Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.
Abstract
Zhang, Hongbing
Chinese Academy of Medical Sciences & Peking Union Medical College
09/12/2011
4.24
Cancer letters
TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade.
Abstract
Gomer, Charles J
Children's Hospital Los Angeles
02/19/2011
4.24
Cancer letters
Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Abstract
Golab, Jakub
Medical University of Warsaw
10/12/2009
4.24
Cancer letters
Photodynamic therapy-driven induction of suicide cytosine deaminase gene.
Abstract
Gomer, Charles J
Children's Hospital Los Angeles
09/03/2009
4.24
Cancer letters
Targeting the 90 kDa heat shock protein improves photodynamic therapy.
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
03/27/2009
4.24
Cancer letters
Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB.
Abstract
Agostinis, Patrizia
Catholic University of Leuven
07/07/2010
4.13
Journal of cellular and molecular medicine
Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage.
Abstract
Chen, Xiangmei
PLA General Hospital and Military Medical Postgraduate College
05/08/2013
4.09
PloS one
Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
06/26/2012
4.09
PloS one
Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.
Abstract
Chen, Jinfei
Nanjing Medical University
12/19/2011
4.09
PloS one
The DNA repair gene APE1 T1349G polymorphism and risk of gastric cancer in a Chinese population.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
12/14/2010
4.09
PloS one
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
05/11/2010
4.09
PloS one
Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.
Abstract
Olivo, Malini
National Cancer Centre, Division of Medical Sciences
11/02/2009
3.99
Molecular cancer
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.
Abstract
Anderson, R Rox
Harvard Medical School
07/16/2010
3.99
Journal of the American Academy of Dermatology
Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy?
Abstract
Maytin, Edward V
Cleveland Clinic
11/20/2009
3.99
Journal of the American Academy of Dermatology
Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.
Abstract
Chen, Qun
South China Normal University
05/31/2010
3.87
Journal of cellular physiology
Inhibitive effects of photofrin on cellular autophagy.
Abstract
Agostinis, Patrizia
Catholic University of Leuven
12/23/2011
3.70
Cancer immunology, immunotherapy : CII
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin.
Abstract
Wulf, H C
University of Copenhagen
01/02/2013
3.67
The British journal of dermatology
Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Abstract
Wulf, H C
University of Copenhagen
05/25/2012
3.67
The British journal of dermatology
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Abstract
Curnow, A
Royal Cornwall Hospital
11/17/2011
3.67
The British journal of dermatology
Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy.
Abstract
Anderson, R Rox
Harvard Medical School
11/17/2011
3.67
The British journal of dermatology
Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methylester: a retrospective, blinded study of patients with field cancerization.
Abstract
Curnow, A
Royal Cornwall Hospital
05/13/2011
3.67
The British journal of dermatology
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Abstract
Wulf, H C
University of Copenhagen
04/05/2011
3.67
The British journal of dermatology
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Abstract
Wulf, H C
University of Copenhagen
03/26/2009
3.67
The British journal of dermatology
Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
02/08/2010
3.64
Laboratory investigation; a journal of technical methods and pathology
Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells.
Abstract
Zhang, Yaou
Tsinghua University
09/19/2011
3.54
FEBS letters
MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin.
Abstract
Chen, Jie
University of Illinois at Urbana-Champaign
09/30/2009
3.54
American journal of physiology. Cell physiology
mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms.
Abstract
Chen, Jun
12/09/2013
3.53
Molecular pain
The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways.
Abstract
Sonenberg, Nahum
McGill University
06/03/2009
3.44
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Current status and challenges associated with targeting mTOR for cancer therapy.
Abstract
Chen, Xiangmei
PLA General Hospital and Military Medical Postgraduate College
08/19/2009
3.44
Mechanisms of ageing and development
Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging.
Abstract
Ikeda, Norihiko
Tokyo Medical University
05/23/2009
3.43
Lung cancer (Amsterdam, Netherlands)
Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Abstract
Durand, Jean-Olivier
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
04/28/2012
3.35
International journal of pharmaceutics
Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Abstract
Durand, Jean-Olivier
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
10/08/2010
3.35
International journal of pharmaceutics
Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
07/16/2009
3.32
Immunology
mTOR: taking cues from the immune microenvironment.
Abstract
Hengstschläger, M
Medical University of Vienna
07/13/2010
3.25
Amino acids
Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236.
Abstract
Hengstschläger, M
Medical University of Vienna
05/13/2010
3.25
Amino acids
Evidence for cell cycle-dependent, rapamycin-resistant phosphorylation of ribosomal protein S6 at S240/244.
Abstract
Hengstschläger, M
Medical University of Vienna
01/15/2009
3.25
Amino acids
mTOR phosphorylated at S2448 binds to raptor and rictor.
Abstract
Hengstschläger, M
Medical University of Vienna
04/02/2008
3.25
Amino acids
Tuberin, p27 and mTOR in different cells.
Abstract
Hall, Michael N
University of Basel
07/18/2013
3.24
Biochemical Society transactions
Talks about TORCs: recent advancesin target of rapamycin signalling. On mTOR nomenclature.
Abstract
Hall, Michael N
University of Basel
07/18/2013
3.24
Biochemical Society transactions
Conserved sequence motifs and the structure of the mTOR kinase domain.
Abstract
Sabatini, David M
Whitehead Institute for Biomedical Research
01/15/2009
3.24
Biochemical Society transactions
Rag proteins regulate amino-acid-induced mTORC1 signalling.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
05/06/2013
3.22
Bioanalysis
Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy.
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
10/26/2012
3.21
Immunobiology
Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1.
Abstract
Awazu, Kunio
Graduate School of Engineering
10/22/2012
3.16
Journal of biomedical optics
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Abstract
Awazu, Kunio
Graduate School of Engineering
10/12/2012
3.16
Journal of biomedical optics
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Abstract
Awazu, Kunio
Graduate School of Engineering
08/16/2012
3.16
Journal of biomedical optics
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Abstract
Awazu, Kunio
Graduate School of Engineering
06/06/2011
3.16
Journal of biomedical optics
Determination of the tumor tissue optical properties during and after photodynamic therapy using inverse Monte Carlo method and double integrating sphere between 350 and 1000 nm.
Abstract
Maytin, Edward V
Cleveland Clinic
11/08/2010
3.16
Journal of biomedical optics
Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.
Abstract
Chen, Qun
South China Normal University
05/12/2010
3.16
Journal of biomedical optics
Quantitative measurement of reactive oxygen species in vivo by utilizing a novel method: chemiluminescence with an internal fluorescence as reference.
Abstract
Olivo, Malini
National Cancer Centre, Division of Medical Sciences
03/09/2010
3.16
Journal of biomedical optics
Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
10/12/2012
3.15
ChemMedChem
Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.
Abstract
Hopper, Colin
University College Hospital
12/07/2011
3.14
Head & neck oncology
Photodynamic therapy and end-stage tongue base cancer: short communication.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
06/09/2010
3.08
Critical reviews in eukaryotic gene expression
mTOR signaling in cancer cell motility and tumor metastasis.
Abstract
Hengstschläger, M
Medical University of Vienna
09/09/2009
3.02
European journal of clinical investigation
CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
09/24/2010
3.01
Cell stress & chaperones
Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy.
Abstract
Wulf, H C
University of Copenhagen
01/07/2013
2.98
Journal of the European Academy of Dermatology and Venereology : JEADV
Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
01/14/2013
2.97
Biological chemistry
Melanoma resistance to photodynamic therapy: new insights.
Abstract
Hengstschläger, Markus
03/16/2009
2.92
Leukemia research
New insights into the role of the tuberous sclerosis genes in leukemia.
Abstract
Powell, Jonathan D
Johns Hopkins University School of Medicine
07/07/2009
2.90
Molecular immunology
Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
03/16/2011
2.89
Current protein & peptide science
Role of mTOR signaling in tumor cell motility, invasion and metastasis.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
08/30/2010
2.89
Current protein & peptide science
The complexes of mammalian target of rapamycin.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
07/29/2013
2.86
Anti-cancer agents in medicinal chemistry
Hitting the golden TORget: curcumin's effects on mTOR signaling.
Abstract
Huang, Shile
Louisiana State University Health Sciences Center
11/12/2010
2.86
Anti-cancer agents in medicinal chemistry
Updates of mTOR inhibitors.
Abstract
Yang, Yunsheng
Chinese PLA General Hospital
12/07/2013
2.81
Journal of photochemistry and photobiology. B, Biology
The potential of photodynamic therapy to treat esophageal candidiasis coexisting with esophageal cancer.
Abstract
Robinson, D J
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
07/11/2013
2.81
Journal of photochemistry and photobiology. B, Biology
Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
Abstract
Chen, Qian
Rhode Island Hospital and Brown University
08/11/2009
2.81
Journal of orthopaedic research : official publication of the Orthopaedic Research Society
The effect of rapamycin on bone growth in rabbits.
Abstract
Blagosklonny, Mikhail V
Roswell Park Cancer Institute
11/01/2013
2.64
Cancer biology & therapy
Dysregulation of the mTOR pathway in p53-deficient mice.
Abstract
Gu, Ying
Chinese Academy of Sciences
05/17/2010
2.62
Mini reviews in medicinal chemistry
Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases.
Abstract
Gu, Ying
PLA General Hospital
11/08/2013
2.61
Lasers in surgery and medicine
Retinal injury thresholds for 532, 578, and 630 nm lasers in connection to photodynamic therapy for choroidal neovascularization.
Abstract
Hopper, Colin
University College Hospital
06/15/2013
2.61
Lasers in surgery and medicine
Strategies of airway management for head and neck photo-dynamic therapy.
Abstract
Hopper, Colin
University College Hospital
07/31/2012
2.61
Lasers in surgery and medicine
Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
06/29/2012
2.61
Lasers in surgery and medicine
Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer.
Abstract
Hasan, Tayyaba
Harvard Medical School
11/07/2011
2.61
Lasers in surgery and medicine
Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Abstract
Ikeda, Norihiko
Tokyo Medical University
11/07/2011
2.61
Lasers in surgery and medicine
Molecular determinants of photodynamic therapy for lung cancers.
Abstract
Anderson, R Rox
Harvard Medical School
11/07/2011
2.61
Lasers in surgery and medicine
Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
Abstract
Olivo, Malini
National Cancer Centre, Division of Medical Sciences
11/07/2011
2.61
Lasers in surgery and medicine
Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
11/07/2011
2.61
Lasers in surgery and medicine
Photodynamic therapy for infections: clinical applications.
Abstract
Gomer, Charles J
Children's Hospital Los Angeles
11/07/2011
2.61
Lasers in surgery and medicine
Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Abstract
Anderson, R R
Harvard Medical School
09/29/2011
2.61
Lasers in surgery and medicine
Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
04/18/2011
2.61
Lasers in surgery and medicine
Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH.
Abstract
Chen, Qun
South China Normal University
08/31/2010
2.61
Lasers in surgery and medicine
Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model.
Abstract
Curnow, Alison
Royal Cornwall Hospital
08/31/2010
2.61
Lasers in surgery and medicine
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
01/19/2010
2.61
Lasers in surgery and medicine
Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model.
Abstract
Robinson, Dominic J
Center for Optical Diagnostics and Therapy, Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.
10/19/2009
2.61
Lasers in surgery and medicine
Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Abstract
Anderson, R Rox
Harvard Medical School
07/15/2009
2.61
Lasers in surgery and medicine
Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients.
Abstract
Hasan, Tayyaba
Harvard Medical School
06/22/2009
2.61
Lasers in surgery and medicine
Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis.
Abstract
Anderson, R Rox
Harvard Medical School
02/24/2009
2.61
Lasers in surgery and medicine
Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin.
Abstract
Wulf, Hans Christian
University of Copenhagen
11/14/2013
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
Artificial daylight photodynamic therapy with "non-inflammatory" doses of hexyl aminolevulinate only marginally delays SCC development in UV-exposed hairless mice.
Abstract
Wulf, Hans Christian
University of Copenhagen
12/13/2012
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
People maintain their sun exposure behaviour in a 5-7-year follow-up study using personal electronic UVR dosimeters.
Abstract
Robinson, Dominic J
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
10/29/2012
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parameters.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
04/09/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
Combination approaches to potentiate immune response after photodynamic therapy for cancer.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
03/24/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
The immunosuppressive side of PDT.
Abstract
Chen, Qun
South China Normal University
03/17/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
In vivo detection of chemiluminescence to monitor photodynamic threshold dose for tumor treatment.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
02/18/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
Combination of photodynamic therapy and immunomodulation for skin diseases--update of clinical aspects.
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
01/24/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
Cancer vaccines generated by photodynamic therapy.
Abstract
Agostinis, Patrizia
Catholic University of Leuven
01/24/2011
2.58
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown.
Abstract
Chen, Jianming
Second Military Medical University
07/28/2011
2.55
Bioorganic & medicinal chemistry
Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
Abstract
Robinson, D J
Department of Dermatology, Erasmus MC, Rotterdam
10/15/2013
2.52
Photodiagnosis and photodynamic therapy
The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
04/17/2012
2.52
Photodiagnosis and photodynamic therapy
Adverse effects associated with photodynamic therapy (PDT) of port-wine stain (PWS) birthmarks.
Abstract
Durand, Jean-Olivier
Laboratoire Réactions et génie des Procédés, UPR 3349, Nancy-Université, 1, rue Grandville, 54000, Nancy
01/31/2012
2.52
Photodiagnosis and photodynamic therapy
Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
Abstract
Hopper, Colin
University College Hospital
01/14/2012
2.52
Photodiagnosis and photodynamic therapy
Treatment of Kimura disease with photodynamic therapy: a case study.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
08/25/2011
2.52
Photodiagnosis and photodynamic therapy
Successful treatment of refractory facial acne using repeat short-cycle ALA-PDT: Case study.
Abstract
Curnow, Alison
Royal Cornwall Hospital
12/17/2010
2.52
Photodiagnosis and photodynamic therapy
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Abstract
Curnow, Alison
Royal Cornwall Hospital
11/05/2010
2.52
Photodiagnosis and photodynamic therapy
Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.
Abstract
Hopper, Colin
University College Hospital
09/09/2010
2.52
Photodiagnosis and photodynamic therapy
Optical coherence tomography-guided photodynamic therapy for skin cancer: case study.
Abstract
Curnow, A
Royal Cornwall Hospital
08/06/2010
2.52
Photodiagnosis and photodynamic therapy
Effect of MAL-photodynamic therapy on hypertrophic scarring.
Abstract
Curnow, Alison
Royal Cornwall Hospital
04/24/2010
2.52
Photodiagnosis and photodynamic therapy
Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Abstract
Robinson, Dominic J
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
02/18/2010
2.52
Photodiagnosis and photodynamic therapy
A dedicated applicator for light delivery and monitoring of PDT of intra-anal intraepithelial neoplasia.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
02/07/2010
2.52
Photodiagnosis and photodynamic therapy
Topical ALA PDT for the treatment of severe acne vulgaris.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
11/25/2009
2.52
Photodiagnosis and photodynamic therapy
Photodynamic therapy for localized infections--state of the art.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
09/10/2009
2.52
Photodiagnosis and photodynamic therapy
Photodynamic therapy in treatment of port wine stain birthmarks--recent progress.
Abstract
Li, Xuejun
Peking University
02/21/2012
2.52
European journal of pharmacology
Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity.
Abstract
Sonenberg, N
02/20/2009
2.47
Current oncology (Toronto, Ont.)
Targeting mTOR-dependent tumours with specific inhibitors: a model for personalized medicine based on molecular diagnoses.
Abstract
Gu, Ying
PLA General Hospital
08/24/2013
2.42
Lasers in medical science
Assessment of tissue perfusion changes in port wine stains after vascular targeted photodynamic therapy: a short-term follow-up study.
Abstract
Curnow, A
Royal Cornwall Hospital
08/28/2012
2.42
Lasers in medical science
Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
Abstract
Gu, Ying
PLA General Hospital
02/16/2011
2.42
Lasers in medical science
Influence of laser wavelength on the damage of comb's vasculature by photodynamic therapy--simulation and validation of mathematical models.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
02/26/2009
2.42
Lasers in medical science
Treatment of perianal Paget's disease using photodynamic therapy with assistance of fluorescence examination: case report.
Abstract
Hasan, Tayyaba
Harvard Medical School
04/04/2013
2.41
Photochemistry and photobiology
PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
02/19/2013
2.41
Photochemistry and photobiology
Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis.
Abstract
Huang, Zheng
Shanghai Skin Diseases and STD Hospital
01/10/2012
2.41
Photochemistry and photobiology
Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy.
Abstract
Curnow, Alison
Royal Cornwall Hospital
09/16/2011
2.41
Photochemistry and photobiology
An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
02/22/2011
2.41
Photochemistry and photobiology
Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress.
Abstract
Robinson, Dominic J
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
11/05/2010
2.41
Photochemistry and photobiology
Fractionated illumination at low fluence rate photodynamic therapy in mice.
Abstract
Curnow, Alison
Royal Cornwall Hospital
11/05/2010
2.41
Photochemistry and photobiology
The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells.
Abstract
Wulf, Hans Christian
University of Copenhagen
11/03/2009
2.41
Photochemistry and photobiology
Vitamin D level in summer and winter related to measured UVR exposure and behavior.
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
10/09/2013
2.40
International journal of oncology
Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
Abstract
Korbelik, M
Wayne State University
12/06/2010
2.40
International journal of oncology
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.
Abstract
Korbelik, Mladen
British Columbia Cancer Agency, Vancouver, BC
10/08/2010
2.38
International immunopharmacology
Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones.
Abstract
Blenis, John
Harvard Medical School
05/20/2013
2.18
Molecules and cells
Nutrient regulation of the mTOR complex 1 signaling pathway.
Abstract
Hengstschläger, Markus
Medical University of Vienna
07/01/2012
2.17
Organogenesis
Amniotic fluid stem cells to study mTOR signaling in differentiation.
Abstract
Li, Xianliang
Sun Yat-Sen University
09/03/2009
2.11
Neuroscience letters
Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
08/13/2012
2.07
Expert review of clinical immunology
Photodynamic therapy induces an immune response against a bacterial pathogen.
Abstract
Hamblin, Michael R
Massachusetts General Hospital
12/17/2010
2.07
Expert review of clinical immunology
Stimulation of anti-tumor immunity by photodynamic therapy.
Abstract
Fluorescence detection methods for microfluidic droplet platforms
Fluorescence detection methods…
PuraMatrix Encapsulation of Cancer Cells
PuraMatrix Encapsulation of Ca…
Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Fluorescence-quenching of a Li…
Thermodynamics of Membrane Protein Folding Measured by Fluorescence Spectroscopy
Thermodynamics of Membrane Pro…
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
One Minute, Sub-One-Watt Photo…
An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm
An In Vitro Model to Study the…
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Cytotoxic Efficacy of Photodyn…
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Anticancer Efficacy of Photody…
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Photodynamic Therapy with Blen…
Targeted Expression of GFP in the Hair Follicle Using Ex Vivo Viral Transduction
Targeted Expression of GFP in …
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
In Vivo Investigation of Antim…
Nanotopology of Cell Adhesion upon Variable-Angle Total Internal Reflection Fluorescence Microscopy (VA-TIRFM)
Nanotopology of Cell Adhesion …
Voltage-sensitive Dye Recording from Axons, Dendrites and Dendritic Spines of Individual Neurons in Brain Slices
Voltage-sensitive Dye Recordin…
The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
The Synergistic Effect of Visi…
Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
Posterior Semicircular Canal A…
JoVE subscription required to view articles
Related JoVE Videos